United States: White House Releases Draft Privacy Principles For The Precision Medicine Initiative

Six months after the Precision Medicine Initiative's (Initiative's) debut, the White House has released a working draft of proposed privacy and trust principles (the Principles) to govern future design and development efforts for the national research cohort envisioned by the Initiative.  This cohort will be a sample population of one million or more Americans, all of whom will provide data for use in research studies. The national research cohort is just one of the Initiative's efforts to use precision medicine—an approach to medical treatment which aims to harness patient-specific information to inform the patient's diagnosis and treatment decisions—to help accelerate biomedical discoveries.

As the longevity, scope, and size of the planned cohort would create new privacy and data security concerns, the administration is trying to safeguard against such concerns prior to the cohort's development. The Principles are the first step in building privacy protections into the cohort's design. The Principles were released in conjunction with other Initiative-related announcements and events, such as the White House's Champions of Change event honoring individuals advancing the precision medicine field. The Principles promote transparency and participant involvement in all stages of the Initiative planning process, and attempt to set broad guideposts to balance data sharing with protecting cohort participants. Most importantly, the Principles provide a noteworthy preview of potential structural and procedural elements, and appear to set a trajectory for how the Initiative's research cohort will develop.

Launching the Precision Medicine Initiative Research Cohort

The Initiative is a research effort launched by President Obama in the 2015 State of the Union address. As we have previously written, the Initiative encompasses multiple funding initiatives, cross-agency directives, and research ventures, all aimed at collecting and using genomic, lifestyle and other clinical data in furtherance of precision medicine research. A signature endeavor of the Initiative is the development of a research cohort study of at least one million Americans who would participate by sharing genomic and clinical data, biospecimens and biofluids, and other information for use by both researchers and participants themselves. From the outset, the Initiative has prioritized participant privacy and security, convening an interagency working group to identify and address potential issues and create guidelines for navigating such issues in the design and development of the cohort.

That working group developed the Principles by leveraging expert roundtables, working group meetings and workshops, reviews of bioethics literature, and analyses of current practices in biobanks and research. In total, the working draft describes twenty-nine Principles in seven topic areas: governance, transparency, reciprocity, respect for participant preferences, data sharing, access and use, data quality and integrity, and security. Some of these topic areas are common among other general research and privacy principles already in place; for example, respecting participant preferences is a core principle of the 1978 Belmont Report addressing U.S. human subjects' research. However, the Principles are unique in their focus on participant inclusion (e.g., transparency and reciprocity topic areas) and on data-specific issues due to the size and scope of the endeavor (e.g., data sharing, data access, and data quality topic areas).

Before describing the Principles, the working draft sets forth certain assumptions regarding the goals of the Initiative research cohort. These assumptions provide a more concrete outline of the way the cohort will eventually operate. For example, they indicate some cohort research data will be available to both participants and to the public, and that a minimum data set will be required from individuals in order to be included in the cohort.

In addition to these assumptions, the working draft also recognizes the need for more concrete data security guidance that the Principles could not provide. The working draft strongly recommends that a separate interdisciplinary team of data experts develop another document outlining a data security framework for the cohort. The assumptions and recommendations made by the working group are themselves fundamentally important in shaping the role and weight of the Principles, and deserve critical focus from stakeholders in their review and comments on the working draft.

Key Proposed Principles

The Principles themselves range from the general and more predictable—participants should be able to withdraw their consent for future research use and data sharing at any time—to newer, more Initiative-specific directives, such as prohibiting data use for targeted advertising. They also reveal details about the cohort that had not been previously highlighted in official reports or other Initiative media. Even though the Principles are organized into thematic categories, approaching them comprehensively suggests broader trends.

Participant Engagement

A primary goal of the Initiative is to involve participants in all stages of the design and development of the Initiative's research cohort. A variety of Principles have embodied this "participant-centered" approach:

  • The cohort should be planned and conducted in partnership with participants, including them at all levels of the oversight, design, and implementation of the cohort. 
  • The cohort should engage in data sharing in a reciprocal manner, providing educational resources and certain medically useful research data to participants. 
  • Participants would remain involved throughout the life of the cohort; researchers could recontact certain participants for future studies.
  • Participants would be asked to help maintain the integrity of their research data, for example, by reviewing, reporting, and requesting changes to their research records if they identify inaccurate demographic or medical information.

Participant Protection

The Principles also seek to protect the privacy and agency of cohort participants:

  • The cohort should have a centralized governance structure to effectively manage participant communications and prevent against potential data misuse. 
  • Certain activities with cohort data, such as advertising or use against the participant in legal proceedings, would be banned. 
  • Given the anticipated scope and duration of the Initiative, a dynamic, iterative consent process would be needed to ensure sufficient participant protection and Initiative transparency. 
  • When analyzing the potential risks and benefits of research with cohort data, reviewers should consider potential risks and benefits to families and communities, such as stigmatization or other social harms, in addition to individual risks and benefits. 
  • In order to access and use cohort data, researchers, institutions, and other authorized data users would have to comply with  cohort-specific binding rules in addition to all other applicable laws regarding human subjects research, data privacy, and security.  Given the additional compliance burdens that would likely follow, stakeholders interested in cohort research activities should be aware of and continue to monitor this directive.

Data Sharing and Use

The Initiative aims to gather large amounts of data for research purposes while ensuring such data is used and shared appropriately. Various Principles reflect this approach:

  • There will be multiple tiers of cohort data access, including access by participants, researchers, and the public. 
  • Certain data restrictions would apply: 
    - researchers would not be able to access participant data for future research without additional informed consent, and participants would have to authorize researchers to contact them in the future; 
    - cohort data could not be sold or used for directed advertising; and  
    - all cohort-related research findings must be published or summarized publicly, regardless of the outcome of the research.

Though not explicitly discussed in the working draft, the cohort will leverage existing research networks to add participants. As such, communities themselves may be involved in initiatives to generate and provide data to, and receiving data from, the cohort. The Principles address engaging and recruiting "communities with varied preferences and risk tolerances" to help design the cohort and identify potential harms, including social harms, that may stem from research with cohort data.

The Principles in Context

The White House released the draft Principles while announcing a host of other patient- and participant-centered efforts by both public and private entities committed to advancing the Initiative. In addition to the Champions of Change event honoring individuals advancing precision medicine, noted above, the White House also announced a cross-office partnership between the Department of Health and Human Services' Office of the National Coordinator for Health IT (ONC) and Office for Civil Rights (OCR) to develop new tools to help patients access their health data. The ONC is developing one such tool, an open-source prototype, which will allow individuals to interface between mobile health applications, patient-generated data, and their medical records. Private-sector endeavors include mobile applications, patient-centered informational campaigns and new data registry capabilities. In this context, the Principles are consistent in their commitment to participant involvement.

As the White House continues to develop the Initiative, the weight of the Principles' influence on cohort development remains to be seen. Compared to the earlier workshops on the Initiative and the cohort, the Principles notably do not address any potential issues with, or special protections for, children participating in the cohort.  Further, the Principles do not specifically address any potential privacy or security issues with the recruitment process, or with the collection and storage of biological specimens. These omissions suggest significant more work will be done to address these and other potential privacy and safety risks.

*    *     *

The White House is soliciting comments on the working draft of the Principles, which are due August 7, 2015. In the interim, stakeholders should continue to monitor this and other Initiative-related activities that may impact their research or clinical practices. A copy of the Principles can be found here.

White House Releases Draft Privacy Principles for the Precision Medicine Initiative

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions